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Abstract
Cystic fibrosis (CF) is characterized by defective mucociliary clearance and chronic airway infection by a complex microbiota.
Infection, persistent inflammation and periodic episodes of acute pulmonary exacerbation contribute to an irreversible
decline in CF lung function. While the factors leading to acute exacerbations are poorly understood, antibiotic treatment
can temporarily resolve pulmonary symptoms and partially restore lung function. Previous studies indicated that
exacerbations may be associated with changes in microbial densities and the acquisition of new microbial species. Given
the complexity of the CF microbiota, we applied massively parallel pyrosequencing to identify changes in airway microbial
community structure in 23 adult CF patients during acute pulmonary exacerbation, after antibiotic treatment and during
periods of stable disease. Over 350,000 sequences were generated, representing nearly 170 distinct microbial taxa.
Approximately 60% of sequences obtained were from the recognized CF pathogens Pseudomonas and Burkholderia, which
were detected in largely non-overlapping patient subsets. In contrast, other taxa including Prevotella, Streptococcus, Rothia
and Veillonella were abundant in nearly all patient samples. Although antibiotic treatment was associated with a small
decrease in species richness, there was minimal change in overall microbial community structure. Furthermore, microbial
community composition was highly similar in patients during an exacerbation and when clinically stable, suggesting that
exacerbations may represent intrapulmonary spread of infection rather than a change in microbial community composition.
Mouthwash samples, obtained from a subset of patients, showed a nearly identical distribution of taxa as expectorated
sputum, indicating that aspiration may contribute to colonization of the lower airways. Finally, we observed a strong
correlation between low species richness and poor lung function. Taken together, these results indicate that the adult CF
lung microbiome is largely stable through periods of exacerbation and antibiotic treatment and that short-term
compositional changes in the airway microbiota do not account for CF pulmonary exacerbations.
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Introduction
Cystic fibrosis (CF) is a hereditary disease characterized by
defective mucociliary clearance and airway obstruction by
dehydrated, mucopurulent secretions [1]. The leading cause of
morbidity and mortality in individuals with CF is respiratory
failure associated with persistent airway infection and inflamma-
tion [2–4]. Traditional aerobic culture-based studies, of sponta-
neous expectorated sputa, indicate that CF airway infection
involves a relatively small collection of opportunistic pathogens
that are typically acquired in a temporal succession, beginning
early in life with Haemophilus influenzae and Staphylococcus aureus and
culminating in chronic infections dominated by Pseudomonas
aeruginosa or Burkholderia cepacia complex species [5]. Additional
opportunistic pathogens, including Stenotrophomonas maltophilia,
Achromobacter xylosoxidans and nontuberculous mycobacterium have
been recovered from adult patients with increasing frequency [6].
The observation that the mucous obstructing CF airways is
hypoxic [7] has led to multiple studies in which CF respiratory
specimens have been analyzed under strict anaerobic culture
conditions [8–10]. These studies have shown that anaerobic
bacterial species are also present within CF airways in high
numbers. The spectrum of facultative and obligate anaerobic
species recovered from CF specimens frequently includes members
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of the genera Streptococcus, Prevotella, Actinomyces and Veillonella. The
use of culture independent molecular detection methods has
greatly expanded our understanding of the complexity of CF
airway disease. High throughput sequencing efforts indicate that
the CF microbiome consists of more than 60 different bacterial
genera, while interrogation of bacterial 16S ribosomal RNA
(rRNA) gene-based phylogenetic microarrays has placed the
estimate at as many as 43 different bacterial phyla and over
2,000 different taxa [11–13].
Despite the complexity and variety of microbial organisms that
can reside in the airways of CF patients, individuals can exhibit
relatively extended periods of stable disease symptoms. These
stable periods are punctuated by episodes of acute pulmonary
exacerbation. While the definition of a pulmonary exacerbation is
controversial, it generally involves a rapid decline in pulmonary
function and worsening of respiratory symptoms, requiring
antibiotic treatment and hospitalization [14]. Patients who
experience more frequent exacerbations have increased morbidity
and mortality [15,16]. Furthermore, recent studies have demon-
strated an association between exacerbation frequency and the
long-term rate of lung function decline [16,17]. The factors
contributing to acute pulmonary exacerbation are poorly under-
stood. Infection by respiratory viruses may be a precipitating event
and some studies suggest that up to a third of CF exacerbations are
associated with viral infection [18]. Other recent studies have
shown a correlation between acute exacerbation and airway
colonization by bacteria belonging to the Streptococcus milleri group
[19–21]. Furthermore, it has been proposed that species of the
genus Prevotella may play a role in exacerbation; however, direct
evidence for this association is lacking [22,23]. Interestingly, both
Streptococcus milleri and Prevotella species are associated with
endogenous anaerobic infections in multiple sites including the
respiratory tract [20,24–26].
Previous studies utilizing aerobic and strict anaerobic bacterial
culture techniques indicate that polymicrobial CF pulmonary
infection persists through multiple rounds of antibiotic treatment
for acute exacerbations [8,10]. The results of these studies raise the
question as to whether acute exacerbations are caused by an
intensification of pre-existing bacterial species, emergence of new
species, or intrapulmonary spread of infection.
The application of high-throughput sequencing provides a
detailed view of the complex microbial communities that exist in
the CF lung [11–13]. In contrast to healthy individuals, CF patients
are subjected to repeated rounds of antibiotics to control chronic
and recurrent respiratory infection. High-throughput sequencing
provides a means to characterize the effects of antibiotics on airway
microbial communities that have likely evolved and adapted in
response to prior antibiotic treatment. Further, comparison of the
microbiome of CF patients experiencing an acute exacerbation to
both post antibiotic and stable intervals may provide insight into the
mechanistic basis of acute exacerbation.
In this study, we collected spontaneous expectorated sputum
from 23 adult CF patients at the beginning of an acute
exacerbation and after one course of antibiotic treatment for the
exacerbation. Further, we collected sputum from 13 of the 23
patients when they were clinically stable and mouthwash samples
from 9 of the patients at multiple timepoints. The sputum samples
Table 1. Antibiotic regimens used to treat acute pulmonary exacerbations in this study1.
Antibiotic regimen Number of exacerbations treated
Tobramycin, Ceftazidime 8
Tobramycin, Piperacillin/Tazobactam 6
Tobramycin, Meropenem 2
Tobramycin, Ciprofloxacin 1
Tobramycin, Temocillin 1
Tobramycin, Ciprofloxacin, Colomycin 1
Tobramycin, Piperacillin/Tazobactam, Meropenem 1
Temocillin, Colomycin 2
Temocillin, Meropenem 1
Piperacillin/Tazobactam, Colomycin, Ciprofloxacin 1
Amikacin, Meropenem 1
Amikacin, Clindamycin, Moxifloxacin, Clarithromycin 1
1Table indicates antibiotic regimens used to treat each of the 26 exacerbations that occurred during the period of study. Of the 23 patients enrolled, three patients
experienced two separate exacerbations. For these three patients, the first and second exacerbations were treated with different antibiotic combinations.
doi:10.1371/journal.pone.0045001.t001
Figure 1. The CF microbiome consists primarily of previously
identified bacterial taxa. Each consensus OTU identified within the
CF sample set was aligned to version 104 of the SILVA database of
bacterial 16S rRNA gene sequences using the program align.seqs in the
software package Mothur as described in Methods. The percent identity
of the resulting global alignment is shown as a function of the number
of sequences in each OTU. The red line represents 97% identity.
doi:10.1371/journal.pone.0045001.g001
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from this patient cohort were previously analyzed for bacterial
content using both culture and culture-independent techniques
[8]. Specifically, the results of quantitative aerobic and anaerobic
culture and quantitative polymerase chain reaction (qPCR) to
determine total bacterial 16S rRNA gene copies were published.
Here, we report further analyses of the samples using 454
pyrosequencing to assess, at high resolution, changes in microbial
community structure and species richness at the onset of
exacerbation, following antibiotic treatment and during intervals
of stable disease. Additionally, we assessed whether pulmonary
function correlated with species richness and microbial densities in
our well-characterized patient cohort.
Results
Antibiotic treatment of acute exacerbations is associated
with temporary improvement of clinical indicators of
pulmonary infection and function
Spontaneous expectorated sputum samples were collected from
23 adult CF patients at the onset of a clinically diagnosed
exacerbation and following the completion of treatment with
intravenous antibiotics. Enrollment and characterization of the
patient cohort, was described as part of a previous clinical study
[8]. Three of the patients were treated twice for an exacerbation
resulting in a total of 26-matched exacerbation/end-of-treatment
sample pairs. A wide range of antibiotic regimens was employed to
treat exacerbations (Table 1). The antibiotic combinations used in
this study were primarily selected to target known pathogens such
as P. aeruginosa and B. cepacia; however, all of the regimens are
expected to have broad-spectrum activity against both Gram-
positive and Gram-negative bacteria. In addition, the majority of
patients also received oral azithromycin or inhaled colistin or
tobramycin as chronic maintenance therapy. Sputum was also
collected from 13 of these patients when clinically stable with 7
samples collected prior to exacerbation, 5 samples collected post-
exacerbation, and one sample collected between treatment of two
separate exacerbations.
Following antibiotic treatment for exacerbation, all patients
showed clinical improvement; lung function, measured as forced
expiratory volume (liters) in 1 second (FEV1), increased signifi-
Figure 2. CF is a polymicrobial disease. Phylogenetic tree of the 169 OTUs identified in the CF sputum dataset. Tree construction was achieved
by mapping consensus sequences from each OTU to the SILVA reference tree (see Methods). Each leaf of the tree represents a consensus OTU labeled
with the most closely related genus assigned by the RDP classifier.
doi:10.1371/journal.pone.0045001.g002
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cantly and white cell count (WCC) and serum levels of C-reactive
protein (CRP) decreased significantly [8]. Antibiotic treatment was
associated with an average decrease (less than one log) in both total
viable bacterial counts and reduced bacterial 16S rRNA gene
copies (as measured by qPCR) in expectorated sputum [8]. For the
13 patients with an additional sputum sample obtained during
stable disease, there was no difference in clinical parameters
(FEV1, CRP, WCC) and bacterial density between the start of an
exacerbation and stable timepoints [8].
Pyrosequencing results are consistent with conventional
culture for dominant pathogens and provide a high-
resolution view of CF microbial community structure
To determine whether changes in CF airway microbial
community structure are associated with exacerbation and
antibiotic treatment, total microbial community DNA was isolated
from expectorated sputum samples and subjected to 454
pyrosequencing targeting the V1–V2 region of the bacterial 16S
rRNA gene. After quality control filtering (see Methods), the
average number of sequences per sample was approximately 4,300
and all samples produced a minimum of 2,292 sequences
(Table S1). Using version 2 of AbundantOTU [27], we identified
a total of 169 non-chimeric microbial Operational Taxonomic
Units (OTUs) at 97% identity in the CF sputum sample set
(Tables S2–S5). A consensus sequence was generated for each
OTU and compared to the SILVA rRNA Database of full-length
16S rRNA gene sequences [28]. The majority of consensus OTU
sequences (77%) matched a reference sequence at 99% identity or
greater (Figure 1). Only two OTUs shared less than 95% identity
with a previously deposited reference sequence, indicating that
nearly all of the taxa encountered in our CF patient cohort were
previously detected in other sequencing projects. Furthermore, the
high level of sequence identify between the OTU sequences
generated here and full-length 16S rRNA reference sequences
demonstrates a low overall rate of sequencing error and that the
quality control pipeline used was sufficient for removing sequenc-
ing artifacts.
A phylogentic tree constructed from the consensus OTU
sequences (Figure 2) shows that the airway microbiota of our CF
patient cohort includes taxa from multiple phyla including
Bacteroidetes, Firmicutes, Proteobacteria, Fusobacteria, Actino-
bacteria and TM7. These results are consistent with previous
studies that have characterized CF as a polymicrobial disease
[8,12,13,29–33]. The majority of sputum derived 16S rRNA gene
sequences were assigned to two OTUs identified as Pseudomonas
(38.5% of sequences) and a single OTU matching the genus
Burkholderia (21.1% of sequences) (Table S2). These results are
consistent with the fact that Pseudomonas aeruginosa and Burkholderia
cepacia complex species are regarded as the dominant pathogens in
adult CF populations and that all but one of the patients enrolled
in this study were culture positive for at least one of these
organisms [5,8]. In contrast to the Pseudomonas and Burkholderia
sequences, multiple distinct OTUs were assigned to other bacteria
genera frequently associated with the oral microbiota, including
Streptococcus, Prevotella and Veillonella (Figure 2, Table S2) [34],
indicating greater diversity within these groups and presumably
the presence of multiple distinct species or subspecies.
Figure 3. There is broad agreement between qualitative bacterial culture results and 454 pyrosequencing for dominant CF
pathogens. The fraction of sequence assigned to the genus (a) Pseudomonas or (b) Burkholderia are plotted for each patient and sample timepoint
as a function of the patient’ s reported culture status for the recognized CF pathogens P. aeruginosa and B. cepacia complex species. Patient samples
are color-coded by timepoint (green, onset of exacerbation; red, end-of-treatment for exacerbation with intravenous antibiotics; blue, clinically stable
interval). Patient 19 was culture negative for both P. aeruginosa and B. cepacia.
doi:10.1371/journal.pone.0045001.g003
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We previously reported quantitative bacterial culture results for
all sputum samples included in this study [8]. To validate the
pyrosequencing dataset, we compared qualitative culture results
(culture positive or culture negative) and relative abundance of
sequences for the dominant CF pathogens Pseudomonas and
Burkholderia for each sputum sample (Figure 3). Patient specimens
that were culture positive for P. aeruginosa had a substantial fraction
of all sequences assigned to the genus Pseudomonas and few
sequences assigned to Burkholderia. Similarly, sputum samples that
were culture positive for B. cepacia complex species had a
substantial number of sequences assigned to genus Burkholderia
and few sequences assigned to genus Pseudomonas.
To determine whether there was quantitative agreement
between the two methods, we directly compared total viable
counts (TVC) as determined by culture [8] and relative sequence
abundance determined by pyrosequencing (Figure 4). Linear
regression between TVC and relative sequence abundance were
highly significant for both Pseudomonas (Figure 4A, black line;
r2 = 0.71, p,0.001) and Burkholderia (Figure 4B, black line;
r2 = 0.86, p,0.001), demonstrating general agreement between
the methods. Despite this agreement, visual inspection of the data
suggest that the relationship between TVC and relative sequence
abundance may be better characterized by a saturating non-linear
model (Figure 4; red lines). This non-linear relationship is
presumably due to the inherent difference between relative and
absolute abundance measures. For example, when the majority of
sequences in a sample are already assigned to a given taxon, a
further increase in the absolute abundance of that taxon cannot be
reflected by a proportionate increase in the relative sequence
abundance. For this reason, changes of more than an order of
magnitude for TVC for P. aeruginosa and B. cepacia are not
necessarily reflected in large changes in relative sequence
abundance (Figure 4). Regardless of the saturation effect seen for
numerically dominant species, this comparison between TVC and
pyrosequencing indicates that relative sequence abundance is a
reliable means for characterizing microbial community structure
and changes in species diversity or richness following antibiotic
disturbance.
Antibiotic treatment reduces low abundance taxa, but
has minimal impact on overall CF microbial community
structure
While a number of recent studies have described the CF airway
microbiome [8,12,13,29–31], none have examined the short-term
longitudinal impact of exacerbation and antibiotic treatment on a
large patient population. The results presented in Figure 3 suggest
that there is general stability of the dominant pathogens as
measured by sequencing at the onset of exacerbation, following
antibiotic treatment (end-of-treatment) and during stable intervals.
Notably, samples taken at the end-of-treatment timepoint did not
consistently show a lower fraction of sequences assigned to
Pseudomonas or Burkholderia compared to samples taken either at the
onset of exacerbation or when patients were clinically stable. To
determine whether other less abundant members of the microbial
community are affected by antibiotic treatment, we compared the
normalized average sequence abundance for all taxa at the onset
of exacerbation and at the end-of-treatment with intravenous
antibiotics (Figure 5A, Table S6). The relative sequence abun-
dance of the individual OTUs was broadly similar at these two
timepoints, indicating that antibiotic treatment did not have a
dramatic affect on overall community structure. To determine
whether the relative abundance of specific taxa was impacted, we
tested the null hypothesis that the distribution of sequence reads
for each OTU was the same at the exacerbation and end-of-
treatment timepoints (Table S6). At a 10% false discovery rate, we
found that the relative sequence abundance of only 7 OTUs
(Gemella, 2 Pasteurella OTUs, 2 Streptococcus OTUs, Oribacterium and
Neisseria; indicated by red symbols in Figure 5A) was higher at the
beginning of an exacerbation than at the end-of-treatment. With
regard to CF airway microbial communities, this result suggests
that antibiotic treatment may have a greater impact on a small
number of less abundant taxa.
Twelve different broad-spectrum antibiotic regimens were used
to treat the 26 exacerbations characterized in this study (Table 1).
To determine if specific antibiotic combinations had a differential
impact on the airway microbiome, we compared the two largest
treatment groups (Tobramycin and ceftzidime versus Tobramycin
and piperacillin/tazobactam) and found no significant differences
in microbial community structure (data not shown). The small
sample size for the remaining treatment regimens precluded
further statistical comparisons.
To determine whether specific taxa were associated with the
onset of exacerbation, we compared the distribution of the
Figure 4. Total viable counts by culture show significant but
non-linear agreement with relative sequence abundance. TVC
for (a) P. aeruginosa and (b) B. cepacia complex species plotted against
the fraction of sequences assigned to the corresponding genera in each
sputum sample. Black lines represent linear regression by least squares
fitting. Values for Pseudomonas (r2 = 0.71, p,0.001) and Burkholderia
(r2 = 0.86, p,0.001) indicate a significant correlation. Red lines are
intended to illustrate a potential non-linear relationship and are based
on the two-parameter Michaelis-Menten function with arbitrarily
selected parameters.
doi:10.1371/journal.pone.0045001.g004
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sequence reads for each OTU at the beginning of exacerbation
and stable timepoints. The pattern of OTUs was highly similar
between these timepoints (Figure 5B). The only obvious outlier in
this relationship was Pseudomonas (Figure 5B, black arrow);
however, the difference in the distribution of Pseudomonas sequence
counts between exacerbation and stable timepoints was not
statistically significant (paired t-test; p = 0.13, n = 13).
Visual inspection of Figure 5A shows that there is a higher
number of taxa under the identity line (Figure 5A, red line) than
over the identity line, suggesting that antibiotic treatment may
affect specific taxa in a patient dependent or antibiotic dependent
manner that is not apparent in the aggregate data. To further
investigate the possibility of patient specific changes in microbial
community structure, we calculated richness (the number of taxa
present) within each sample. Richness was lower at the end-of-
treatment timepoint than at other timepoints (Figure 5C), although
this difference did not reach statistical significance (paired t-test,
p = 0.06). Despite this trend towards lower richness, the overall
similarity of the distributions of taxa between the exacerbation and
end-of-treatment timepoints (Figure 5C) demonstrates that antibi-
otic treatment does not lead to wholesale restructuring of the
microbial community.
Infection types, defined by the dominant CF pathogens
Pseudomonas and Burkholderia, are not associated with
distinct microbial communities
A previous study partitioned the CF airway microbiome into
core and satellite taxa, as a means to distinguish microbial species
that are present in nearly all CF patients from those that display a
more variable distribution among patients, respectively [29]. The
authors observed a positive correlation between the number of
patients that harbored a given taxon and the mean abundance of
that taxon [29]. This relationship was also apparent in our patient
cohort, where the average number of sequences for each taxon
shows a positive linear correlation (Kendall rank correlation;
p = 3.12610205) with the number of samples in which that taxon
is present (Figure 6, Table S7). In other words, high abundance in
one sample is an indicator that a taxon is likely to be prevalent in
the patient cohort.
The two most obvious outliers in this relationship are the OTUs
assigned to Pseudomonas and Burkholderia, which appear to have a
very different distribution from other taxa in our study; they are
highly abundant when present, but are only detected in largely
non-overlapping patient subsets (Figure 3). Previous studies have
demonstrated that microbial community structure involves com-
plex interactions between the constituent members and that
overall community composition is impacted by numerically
dominant species [20,35]. Since Burkholderia and Pseudomonas
account for the majority of all the sequences observed in this
study, and the presence of Burkholderia and Pseudomonas tends to be
mutually exclusive in our dataset, we predicted that the presence
of these organisms would have a differential impact on the
composition of their respective microbial communities. To
determine whether distinct community structures existed within
Figure 5. Abundance taxa are highly stable during exacerba-
tion and in response to antibiotic treatment. To determine
whether the relative abundance of specific taxa changed during
exacerbation or following antibiotic treatment, the normalized average
sequence abundance for all detected OTUs was compared (a) between
exacerbation (n = 22) and end-of-treatment timepoints (n = 22) and (b)
between the exacerbation (n = 22) and stable timepoints (n = 13). For
each taxon, normalized average sequence abundance values are
plotted as a logarithm to the base 10 (log10). Red circles indicate taxa
that had significantly lower normalized average sequence abundance
following antibiotic treatment at a 10% false discovery rate. (c)
Comparison of overall microbial richness at all three sampling
timepoints indicates a slight, but transient decrease following antibiotic
treatment. By pairwise t-tests, comparisons of richness between
exacerbation and end-of-treatment (p = 0.06, n = 21), exacerbation and
stable (p = 0.87, n = 13) and stable and end-of-treatment (p = 0.076,
n = 13) timepoints all fail to reach statistical significance at a p#0.05
threshold.
doi:10.1371/journal.pone.0045001.g005
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our patient population, we performed a principal coordinates
analysis (PCoA) of all sputum samples. Replacing the relative
abundance data for each OTU with the first two principal
coordinates resulted in a clear separation of the Pseudomonas and
Burkholderia dominated communities (Figure 7A; Table 2). To
determine if these differences were reflected in taxa other than
Burkholderia and Pseudomonas, we repeated the PCoA after excluding
all Burkholderia and Pseudomonas sequences. When the Pseudomonas
and Burkholderia sequences were removed, nearly all of the
distinctions between the microbial communities were lost
(Figure 7B; Table 2). Moreover, when we tested the null
hypothesis that a given taxon is differentially represented in
Pseudomonas or Burkholderia dominated communities, only the two
Pseudomonas OTUs and one Burkholderia OTU were detected at a
10% false discovery rate (Table S8). These results suggest that
Pseudomonas and Burkholderia infections occur against a relatively
stable background of other members of the microbial community.
Individuals have distinct airway microbial communities
that are stable over time but show subtle transient
changes following antibiotic treatment
While the largest difference in CF airway microbial community
structure was associated with infection by Pseudomonas or
Burkholderia, PCoA revealed subtle patterns associated with time-
point (Figure 7C–D; Table 3) and individual patients (Figure 7E–
F; Table 2). For example, in most patients, end-of-treatment
samples tend to separate from the corresponding exacerbation
samples, based on both the first and second coordinates of the
PCoA (Figure 7C). Although the magnitude of this difference is
small, it is observed consistently across patients and we are
therefore able to reject the null hypothesis that the exacerbation
and end-of-treatment timepoints cluster together (Table 3; coor-
dinate 1, p = 3.1561025; coordinate 2, p = 0.01). When Pseudomo-
nas and Burkholderia sequences are removed, the distinction
between exacerbation and end-of-treatment timepoints is more
pronounced (Table 3; coordinate 1, p = 9.5461026; coordinate 2,
p = 0.002) and it is apparent that both the stable and exacerbation
timepoints tend to cluster separately from the end-of-treatment
timepoints (Figure 7D, Table 3). As was the case when we
examined each OTU individually (Figure 5), PCoA analysis
revealed a measurable but transient effect of antibiotics on the
end-of-treatment samples, while the exacerbation and stable
timepoints were largely indistinguishable. Taken together, these
results emphasize the resilience of the microbial community and
the short-term effects of antibiotic treatment.
Likewise, samples taken at different timepoints from the same
individual tended to cluster more closely over time (Figure 7E–F),
and this clustering is apparent whether or not sequences from
Pseudomonas and Burkholderia are included (Table 2). Because each
patient was defined by bacterial culture as either Pseudomonas- or
Burkholderia-positive, patient ID is confounded by culture results.
To avoid this problem, we analyzed the Pseudomonas- and
Burkholderia-positive patient groups separately. Despite the limited
sample size for the two infection types (Pseudomonas-positive, n = 14;
Burkholderia-positive, n = 8), we were able to reject the null
hypothesis that individual patients have distinct microbiomes over
time, for at least one principle coordinate (Table 2). The finding
that individuals have unique microbiomes is consistent with other
studies that have shown a distinct individual signature that is
maintained over longitudinal sampling [36,37].
CF airway and oral microbial communities are highly
similar
Numerous studies have noted that the majority of facultative
and obligate anaerobes detected in CF respiratory samples are
typically associated with the normal human oral microbiota
[20,29,32,38]. The use of careful sampling methods and the
apparent density of these organisms in sputum strongly suggest
that their presence is not explained by sputum contamination with
saliva [32,39]. To examine the overlap between the CF airway and
oral microbiota and to better characterize the contribution of oral
flora in CF airway infection, we collected mouthwash samples for
a subset of 9 CF patients at different timepoints (n = 22 samples)
(Table S1). To characterize the oral microbiota, total microbial
DNA was extracted from mouthwash samples and was sequenced
and analyzed in parallel with the corresponding sputum samples
(see Methods). With few exceptions (most notably Pseudomonas), the
average relative abundance of taxa observed in the mouthwash
samples was highly similar to that observed in sputum samples
Figure 6. Prevalent taxa are also abundant taxa. Plot showing the log transformed (log10) average normalized sequence counts for each taxon
compared to the number of samples in which the taxon is present. Averaged values only include samples in which the taxon is present. Only taxa
present in two or more samples (155 OTUs) are plotted. Raw data used to generate used for this analysis are available in Table S7. Red symbols
indicate recognized dominant CF pathogens.
doi:10.1371/journal.pone.0045001.g006
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(Figure 8). At a 10% false discovery rate, the Wilcoxon signed-rank
test detected only two OTUs (Pseudomonas and Rothia) that showed
a different distribution between mouthwash and sputum; with
Pseudomonas being more abundant in sputum and Rothia more
prevalent in mouthwash (Table S9). A parametric t-test recovers
six additional OTUs classified as Granulicatella (2 OTUs) and
Streptococcus (four OTUs) that show a higher relative abundance in
mouthwash compared to sputum (Table S9). It is important to
Figure 7. Sequence signatures discriminate between infection types, timepoint and individual patient. A principal coordinates analysis
(PCoA) of the sputum sample sequence data was performed using Bray-Curtis distance. (a, b) PCoA with samples color-coded by patient’ s reported
culture status for the recognized CF pathogens P. aeruginosa (blue), B. cepacia complex species (red) or those that were culture negative for both
(green). (c, d) PCoA in which samples are color-coded by timepoint; onset of acute exacerbation (EX, green), end-of-treatment with antibiotics (EOT,
red) or when clinically stable (blue). (e, f) PCoA with samples color-coded by individual patient ID. Each sample is indicated by a symbol labeled with
patient ID and timepoint (EX, onset of exacerbation; EOT, end-of-treatment with intravenous antibiotics; ST, clinically stable interval). (a, c, e) PCoA
includes all taxa that had at least 10 sequences in the dataset. (b, d, f) PCoA with all Pseudomonas and Burkholderia sequences removed from the
dataset. Relative abundance data (Table S3) for each OTU were log-transformed and normalized before Bray-Curtis dissimilarities were calculated and
analyzed using the PCoA algorithm in the program Mothur as described in the Methods.
doi:10.1371/journal.pone.0045001.g007
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note, however, that our sample size is small (with mouthwash
samples from only 9 individual patients). It is likely that a survey
with a larger sample size could detect more taxa that are different
between mouthwash and sputum. Within the limits of our sample
size, however, our results indicate an underlying CF airway
microbiome that is largely reflective of the oral cavity.
Microbial richness shows significant correlations with
patient clinical status
Recent studies using both Sanger sequencing and 454
pyrosequencing methods have found a relationship between
reduced species diversity (as measured by richness or Shannon
diversity) and reduced respiratory function (as measured by FEV)
[29,40]. We have shown that a two-week course of intravenous
antibiotics only modestly diminishes the richness of CF airway
microbial communities (Figure 5C), and that this effect is
temporary, with richness similar at exacerbation and stable
timepoints. As richness is broadly stable across time, we calculated
an average richness for each patient by pooling all samples
associated with the patient. Average richness, calculated in this
way, correlated well (r2 = 0.42, p = 0.0009) with FEV1, a broad
measure of the respiratory function, in our cross-sectional analysis
(Figure 9). Our results are, therefore, in agreement with the
existing literature [29,40].
We also determined if total microbial abundance was similarly
correlated with FEV1. Microbial abundance was previously
calculated for all samples in this study by determining TVC by
culture and by qPCR targeting the 16S rRNA gene [8]. While
these two metrics correlate well with each other (Figure 10A;
r2 = 0.63, p,0.0001), neither TVC (Figure 10B; r2 = 0.017,
p = 0.55) or qPCR data (Figure 10C; r2 = 0.003, p = 0.8) correlated
with FEV1. When we only examined TVC associated with B.
cepacia complex species (Figure 10D; r2 = 0.29, p = 0.13) or P.
aeruginosa (Figure 10E; r2 = 0.26, p = 0.05), there was at best a
modest correlation with FEV1. Therefore, we conclude that
microbial richness is a better predictor of FEV1 (Figure 9) than
measures of total microbial abundance (Figure 10). This is also
consistent with a previous study in which total bacterial density
remained constant over time despite changes in diversity that were
associated with decreased lung function as measured by FEV1
[40].
Given the similarity between the oral microbiota and airway
microbiota described above, we determined whether reduced
FEV1 was reflected in reduced diversity in the oral microbiota.
Table 2. P-values derived from PCoA for comparisons between individuals and patient groups defined by culture status.
P-values
All sequences
Pseudomonas and Burkholderia sequences
excluded
Null hypothesis Coordinate 1 Coordinate 2 Coordinate 1 Coordinate 2
1Patients with Burkholderia (n = 8) and Pseudomonas (n = 14)
cluster together.
0.0002 0.008 0.10 0.71
2Samples from individual patients with Pseudomonas (n = 14)
cluster together (40 timepoints).
0.06 0.003 0.02 0.08
2Samples from individual patients with Burkholderia (n = 8)
cluster together (18 timepoints).
0.04 0.13 0.11 0.64
2Samples from individual patients (n = 23)
cluster together across time.
0.0003 0.0004 0.001 0.15
1The average value for each coordinate of the PCoA was taken for each patient (collapsing across all timepoints) and the Wilcoxon test was used to evaluate the
hypothesis that the distribution of the resultant average coordinates was the same for Pseudomonas- and Burkholderia-positive patients.
2To evaluate whether patients from the same culture status group clustered together across time, we used the Krusall-Wallis test with a factor of patient ID in which
samples from different timepoints were treated as repeated samples for each patient. Because patients who were culture positive for Pseudomonas and Burkholderia
clustered separately, we performed the analysis on each patient group as well as a combined analysis on all patients (Pseudomonas-positive, n = 14; Burkholderia-
positive, n = 8; culture negative, n = 1).
doi:10.1371/journal.pone.0045001.t002
Table 3. P-values derived from PCoA for comparisons between sampling timepoints.
P-values1
All sequences
Pseudomonas and Burkholderia sequences
excluded
Null hypothesis Coordinate 1 Coordinate 2 Coordinate 1 Coordinate 2
Exacerbation timepoints and end of treatment
timepoints have the same distribution (n = 21)
3.1561025 0.01 9.5461026 0.002
Exacerbation timepoints and stable timepoints have
the same distribution (n = 13)
0.22 0.38 0.38 0.8926
End of treatment timepoints and stable timepoints
have the same distribution (n = 13)
0.19 0.946 0.02 0.11
1All P-values are the result of the paired t-tests.
doi:10.1371/journal.pone.0045001.t003
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Similar to sputum samples, the average richness of microbial
species detected in mouthwash samples from the nine CF patients
showed a modest correlation with lung function (Figure 11;
r2 = 0.42, p = 0.057); however, the correlation did not reach the
threshold of statistical significance. Given the small sample size,
this observation suggests that a larger study of diversity in CF
patient mouthwash samples is warranted. Despite the limited
number of mouthwash samples examined, these results suggest
that CF lung function may correlate with microbial diversity at
multiple body sites.
Discussion
Within the CF patients in our cohort, we observed a largely
stable overall structure of the airway microbial community, despite
antibiotic treatment and changes in disease status (Figure 5). For
the 23 patients included in this study, we observed many species
belonging to the genera Streptococcus, Prevotella, Rothia, Veillonella,
Actinomyces, and Granulicatella and a single numerically dominant
pathogen, either Pseudomonas or Burkholderia (Figures 2–3). With few
exceptions, the taxa reported here are well represented in Sanger-
based sequencing and culture-based CF studies, suggesting that
the adult CF microbial community has a distinct signature that
can be successfully detected with multiple technologies [8,9,12,29].
Recent studies have emphasized the successional progression
and loss of microbial diversity as a function of CF patient age
[13,30]. Our study suggests that at the end point of this succession,
poor lung function is associated with a low-diversity community
(Figure 9) that it is largely resistant to changes in the face of
antibiotic treatment (Figure 5). Similar findings have recently been
reported for patients with COPD [41]. Sampling of either
expectorated sputum or mouthwash largely reflects the same
microbes, with the possible exception of dominant aerobic airway
pathogens (Figure 8). Interestingly, while loss of species richness is
associated with decreased lung function (Figure 9), we did not find
a significant relationship between total abundance of bacteria and
decreased lung function (Figure 10). Further, our data generally do
not support either intensification or the overgrowth of a particular
pathogen or the acquisition of new microbial community members
as the cause of acute exacerbations in this patient cohort (Figure 5).
This is consistent with a recently published study that observed
total bacterial density remaining stable in CF patients even as FEV
deteriorated over time [40]. Overall, these findings support the
hypothesis that exacerbation represents the spread of infection to
previously unaffected airways. Alternatively, exacerbation may be
the consequence of further adaptations of the microbial commu-
nity to the airway environment such as a change in the expression
of virulence traits by one or more species within the community.
For example, during chronic CF airway infection, P. aeruginosa can
undergo conversion from a smooth to mucoid colony phenotype,
due to over production of the capsular polysaccharide alginate
[42]. Mucoid conversion within the P. aeruginosa population is
associated with a host hyperimmune response and a more rapid
decline in lung function [43,44]. Future studies will be necessary to
determine whether exacerbation involves the spread of infection or
a change in the behavior of the microbial community.
The finding that microbial community composition did not
substantively change with antibiotic treatment is perhaps surpris-
ing given that the majority of these patients were treated for two
weeks with a combination of broad-spectrum antibiotics (Table 1).
While there was a small decrease in richness following antibiotic
treatment (Figure 5C), the changes appear to be largely limited to
taxa that were already of low relative abundance (Figure 5A).
Moreover, change in OTU relative abundance following antibiotic
treatments was statistically significant in only a small number of
taxa at a 10% false discovery rate (Figure 5A; red symbols). While
a larger sample size might detect significant changes in more taxa,
it is clear that the most abundant taxa in this cohort (including
Prevotella, Actinomyces, Granulicatella, Streptococcus, Burkholderia, Veillo-
nella, Rothia and Pseudomonas) showed little change in response to
antibiotics (Figure 5A). This observation may be due to the fact
that antibiotic resistance is widespread throughout many abundant
members of the microbiota cultured from the sputum of adult CF
patients including P. aeruginosa and B. cepacia complex species [45–
47]. As the cost of whole genome sequencing continues drop, it
will be interesting to see if the mechanisms of antibiotic resistance
Figure 8. Mouthwash and sputum samples have a highly
similar distribution of taxa. To determine whether oral flora
contribute to CF airway microbial communities, we compared the
normalized average sequence abundance of all OTUs found in 22 paired
mouthwash and sputum samples from 9 patients. For each taxon,
normalized average sequence abundance values are plotted as a
logarithm to the base 10 (log10). Red symbols indicate taxa that had
significantly different distribution between sample types at a 10% false
discovery rate from a parametric t-test in which the 22 samples were
treated as independent measurements.
doi:10.1371/journal.pone.0045001.g008
Figure 9. Low species richness in sputum samples is associated
with decreased lung function. Shown is a plot of the average FEV1
compared to average microbial richness in sputum for each patient.
FEV1 and microbial richness values were averaged across all timepoints
for each patient. Numbers next to each symbol indicate patient ID.
Symbols are color-coded based on patient culture status (P. aeruginosa,
blue; B. cepacia complex species, red; culture negative for both, green).
Results from linear regression analysis (red line) indicate a significant
correlation (r2 = 0.42, p = 0.0009).
doi:10.1371/journal.pone.0045001.g009
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in each of these taxa can be located and if the acquisition of
resistance elements can be followed longitudinally in individual
patients as they age.
One limitation of our results is that they are dependent on a
quantitative interpretation of high-throughput pyrosequencing
data. While next generation sequencing has generated an
unprecedented, detailed view of microbial communities within
the human body, current PCR-based technology is prone to
saturation effects. Since the CF microbial community can be
dominated by a relatively small number of pathogens, these
saturation artifacts may be more pronounced than in other
polymicrobial diseases. We observed that the agreement between
culture and relative sequence abundance is best described by a
non-linear model (Figure 4). Moreover, absolute measures of
abundance, such as TVC and qPCR targeting the 16S rRNA
gene, show a small, but statistically significant, response to
antibiotics [8]; whereas, our relative sequence counts largely show
stability of microbial community structure in response to
antibiotics (Figure 5A). The differences between the two methods
may be due to the inherent differences between relative and
absolute measurements of abundance. For many of the samples in
which Pseudomonas or Burkholderia were detected, their associated
sequences represent more than 50% of the reads in the sample
(Figure 3). Under these conditions, further large increases in
Pseudomonas or Burkholderia would not be detected by sequencing as
the majority of sequences are already assigned to these dominant
pathogens. While pyrosequencing may not detect changes in
absolute density of numerically dominant microbial community
members, the fact that we detected a similar distribution of taxa in
sputum and mouthwash samples (Figure 8), which harbor
Figure 10. Lung function is not correlated with total bacterial abundance. Measurements of total bacterial abundance in sputum by (a) TVC
and qPCR are well correlated (r2 = 0.63, p,0.0001; n = 23). FEV1 is not correlated with (b) TVC (r
2 = 0.017, p = 0.55; n = 23) or (c) qPCR (r2 = 0.003, p = 0.8;
n = 23) and only modestly correlated with TVC from (d) B. cepacia complex species (r2 = 0.29, p = 0.13; n = 8) and (e) P. aeruginosa (r2 = 0.26, p = 0.05;
n = 14). Measurements for bacterial abundance and FEV1 were averaged across timepoints for each of the 23 patients. Labels in each panel indicate
patient ID. Lines indicate regression fit by linear least squares. Only TVC values .0 were included for B. cepacia and P. aeruginosa comparisons. TVC
values represent log10 of total bacterial colony forming units (CFUs) recovered per gram of sputum. qPCR values represent log10 copies of the
bacterial 16S rRNA gene detected per gram of sputum.
doi:10.1371/journal.pone.0045001.g010
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substantially fewer dominant pathogens, strongly suggests that the
observed overall community structure is not a result of saturation
artifacts.
In the present study, mouthwash and spontaneous sputum
samples had a very similar distribution of taxa, with the exception
of the pathogens Pseudomonas (Figure 8) and a small number of
other taxa (Table S9). This finding is similar to that recently
reported for healthy individuals where bacterial communities from
the lung displayed compositions indistinguishable from the upper
airways [48]. A number of studies have clearly shown that
detection in sputum of bacteria, which are members of the normal
oral microbiota, is not a result of contamination of the sputum
sample during collection [9,39]. Furthermore, these bacteria are
also present in low numbers in the lungs of healthy individuals,
healthy smokers and patients with other respiratory diseases
characterized by chronic infection such as COPD [41,48].
Therefore, our findings suggest that the oral cavity could serve
as a reservoir for respiratory infection with sputum seeded during
small-volume aspiration.
Members of complex microbial communities are known to
exhibit both mutualistic and antagonist relationships. Therefore, it
is reasonable that we would detect different microbial community
organization in patients who had a Pseudomonas dominated
infection compared to patients with a Burkholderia dominated
infection. However, our data do not support this hypothesis. When
we remove Pseudomonas and Burkholderia sequences from our data
set, the underlying microbial community structures were largely
indistinguishable (Figure 7B; Table 2). Moreover, with the
exception of Pseudomonas and Burkholderia, taxa that are present in
a large number of patients also tend to be present in the highest
abundance (Figure 6). Taken together, these data suggest that
Pseudomonas and Burkholderia infections occur in the context of a
highly stable microbial community that is on average, broadly
similar across patients. Pseudomonas and Burkholderia are closely
related organisms and it may be that they can play similar
ecological roles in the communities in which they exist.
Alternatively, the underlying microbial community, which may
be continually reseeded by aspiration from the oral cavity, may
only support or select for a subset of non-endogenous opportu-
nistic pathogens with a related metabolic capacity.
In summary, we have observed a surprising degree of stability in
microbial community composition across sample types and before
and after antibiotic treatment of adult patients infected with a
range of opportunistic pathogens. Taken together with recent
successional studies that have documented higher diversity in
children with CF [13,30], our study supports a model of CF in
which a diverse but unstable microbial community associated with
children is reduced to a smaller set of highly resistant taxa in adults
that are stable across time and space. This model is consistent with
the recent observation that lifetime exposure to antibiotics in CF
patients is associated with lower FEV and lower microbial diversity
[40]. Our data further suggest that the loss of lung function
associated with acute exacerbation may reflect intrapulmonary
spread of infection to previously unaffected airways rather than a
change in microbial density or composition of the airway
microbial communities. Future studies that exploit the cultivability
of nearly all CF taxa [31] and the increasingly low cost of
obtaining whole-genome sequences of cultured taxa may deter-
mine the specific molecular mechanisms by which a child’ s high-
diversity microbiome is replaced in adulthood with a low-diversity
highly resistant microbiome. Finally, we conclude that long-term
changes in microbial community structure (richness) are likely to
be associated with the slow decline in CF lung function over time.
Methods
Ethics Statement
This study was conducted with the approval of the Office for
Research Ethics Northern Ireland and all study participants
provided informed written consent.
Patient selection and collection of samples
Details of the CF patient cohort were previously published as
part of an earlier study in which the airway microbiota was
characterized by aerobic and anaerobic bacterial culture, qPCR
and by terminal restriction fragment length polymorphism analysis
of bacterial 16 S ribosomal RNA genes present in sputum [8].
Exacerbations were defined according to the criteria of Fuchs
et al. (1994) and treated with a range of antibiotic [49] (Table 1).
In brief, sputum samples were collected at the onset of
exacerbation (24 hours before to a maximum of 48 hours after
administration of the first dose of intravenous antibiotics) and at
the completion of antibiotic treatment (24 hours before to a
maximum of 48 hours after last dose of antibiotics). In addition,
sputum samples were collected from 13 patients when clinically
stable; defined as no change in symptoms, FEV1 within 10% of
best value in the previous 6 months and no new antibiotics started.
Spontaneously expectorated sputum was collected and trans-
ported within 15 minutes to an anaerobic cabinet for processing.
All samples were divided with one aliquot immediately processed
for culture [8] and a second aliquot frozen and stored at 280uC
for subsequent DNA extraction.
Mouthwash samples were collected from a subset of nine
patients immediately prior to sputum collection at the time of
exacerbation and/or at the end of antibiotic treatment. Patients
gargled a 10 ml volume of sterile saline (0.9%) for 30 seconds, and
wash fluid was collected in a sputum pot. Samples were frozen and
stored at 280uC for subsequent DNA extraction.
DNA was extracted from frozen sputum samples as previously
described [8]. Mouthwash samples were thawed and centrifuge at
4uC, at 17,0006g for 10 minutes. Total DNA was isolated from
the pelleted material using the FastDNA Spin Kit and FastPrep
Figure 11. Low species richness in mouthwash samples is
associated with decreased lung functions. Shown is a plot of the
average FEV1 compared to average microbial richness in mouthwash
samples for nine patients. FEV1 and microbial richness values were
averaged across all timepoints for each patient. Numbers next to each
symbol indicate patient ID. Results from linear regression analysis (red
line) showed a modest correlation with lung function (r2 = 0.42,
p = 0.057).
doi:10.1371/journal.pone.0045001.g011
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Instrument (MP Biomedicals) according to the manufacturer’ s
protocol. Isolated DNA was passed over a Zymo-Spin IV-HRC
column (Zymo Research) and the concentration of recovered
DNA determined using Quant-iT PicoGreen dsDNA reagent
(Invitrogen).
Amplification and barcoding of bacterial 16S rRNA gene
amplicons
The 454 Life Sciences primer B (bold) with a ‘‘TC’’ linker and
bacterial 27F primer (underlined) (59-GCCTTGCCAGC
CCGCTCAGTCAGAGTTTGATCCTGGCTCAG-39) and
primer A (bold) with an 8 nucleotide barcode (N), ‘‘CA’’ linker,
and bacterial primer 338R (underlined) (59-GCCTCCCT
CGCGCCATCAGNNNNNNNNCATGCTGCCTCCCGTAG-
GAGT-39) were used to target the V1-V2 variable regions of the
bacterial 16S rRNA gene. Primer design and barcode sequences
were as previously described [50]. PCR amplification of the 16S
rRNA gene was performed with barcoded primers as previously
described, using AmpliTaq Gold 2x Mastermix (Applied Biosys-
tems) [51]. For each patient sample, one or more PCR reactions
were pooled to achieve a minimum of 50 ng of amplicon. All
reactions were cleaned and concentrated with Montage PCR
Clean-Up Kit (Millipore), and DNA concentrations determined
with Quant-iT PicoGreen dsDNA Assay Kit from Molecular
Probes (Life Technologies) on a Synergy HT fluorescent plate
reader from BioTek Instruments. Volumes representing equal
mass of DNA were pooled into a single tube and concentrated
using a Qiaquick PCR Purification Kit (Qiagen Inc.) DNA was
briefly subjected to SpeedVac (Thermo Scientific) with heating to
ensure all residual ethanol was removed.
Pyrosequencing and sequence quality control filtering
Pyrosequences were generated using the 454-FLX chemistry
platform (Roche) on two separate sequencing plates at the
University of North Carolina High Throughput Sequencing
Facility. Sequences not having an exact match to a 59 primer
were removed from the dataset. The program Lucy (v. 1.20) [52]
was used to end-trim the remaining sequences to a quality score
(Q-score) of 27 (p = 0.002) as previously recommended [53].
Additional trimmed sequence were removed from the dataset
based on the following criteria: (i) the trimmed sequence contained
any N’ s; (ii) the trimmed sequence was shorter than 180 base pairs
or longer than 470 base pairs or (iii) the 59 region was identified as
low-quality by Lucy in the untrimmed sequence (below a Q-score
of 27). A total of 405,888 sequences met these criteria and were
used for subsequent analysis in version 2 of AbundantOTU [27].
Using default parameters (which cluster sequences with an average
percent identity of 97%), AbundantOTU clustered 97.8% of the
405,888 sequences into OTUs. Sequences that were not incorpo-
rated into an OTU were removed from further analysis. The
consensus sequences for each OTU were analyzed with the Broad
Institute’ s implementation of ChimeraSlayer [54]. 34 chimeric
OTUs were detected and removed from downstream analysis.
The program UCHIME [55] was run on the remaining consensus
sequences with the Gold database as reference. UCHIME
reported no chimeras among these 177 consensus sequences,
which were used for further analysis.
To remove non-microbial sequences, we mapped each consen-
sus sequence to version 10.22 of the RDP database [56] using the
64 bit version 2.2.18 of NCBI’ s BLAST. All but two consensus
sequences (Consensus172 and Consensus202) matched to a known
microbial sequence within the RDP database with an alignment
length of at least 183 base pairs and a percent identity of at least
95.8%. Comparison of the consensus sequences with the same
version of BLAST to version 104 of the SILVA reference tree
(http://www.arb-silva.de/) yielded similar results; all but the same
two consensus sequences matched to a known microbial sequence
in the SILVA database with an alignment length of at least 113
base pairs and a percent identity of 95.4%. Using NCBI BLAST
(http://blast.ncbi.nlm.nih.gov/Blast.cgi) against the NR database
on the two consensus sequences that did not match either RDP or
SILVA revealed that one of the consensus sequences was a human
contaminant and the other had no matching sequences in the NR
database. These two OTUs were therefore removed from
downstream analysis resulting in a total of 175 consensus OTUs
generated from the 85 samples examined in this study (63 sputum,
22 mouthwash). Figure 1 shows the results of using the program
align.seqs in the package Mothur [57] to map the sputum-derived
non-chimeric microbial consensus sequences to version 104 of the
SILVA database. To reduce the memory requirements of the
align.seqs method, only the SILVA sequences that were detected
by the BLASTN search of the consensus sequences were included
in the ‘‘template’’ file for the align.seqs search.
Table S1 shows the number of sequences for each sputum
sample that passed all QC steps and were included in a non-
chimeric OTU for which the consensus sequence mapped to a
known microbial sequence. Because all of the consensus sequences
for each of the OTUs in our analysis pool had an excellent
(.95%) match by BLAST to the SILVA reference tree and all but
two of the consensus sequences had a .95% match across the
global alignment produced by align.seqs (Figure 1), the SILVA
reference tree was used as a basis for creation of the phylogenetic
visualization in Figure 2. Within the SILVA reference tree, each
consensus sequence was substituted for the node on the tree that
had the closest match (as determined by the align.seqs program in
Mothur). All other nodes were removed from the tree using
custom Java code and the function deleteSubtree from the
function org.forester.phylogeny Phylogeny within the Archaeop-
teryx (http://www.phylosoft.org/archaeopteryx/) source code.
Each reference sequence in the SILVA database was classified
with v. 2.1 of the standalone version of the RDP classifier and the
most refined classification at a confidence score of 80% was used
to label each leaf in Figure 2. This was accomplished with custom
Java code to produce a PhyloXML file, which was visualized with
Archaeopteryx.
Sample normalization
In our dataset, the number of sequences per sample ranged
from 2,292 to 7,212 with an average of 4,300.1 sequences per
sample. To correct for variation in total sequence counts between
samples, the abundance of each OTU in a given sample was
standardized by calculating the logged sequence abundance using
the following formula:
log10 ((
frequency
num sequences in sample
)
average # of sequences per samplez1)
The logarithm was used to lessen the influence of more
dominant OTUs. In order to take the log of zero, a pseudo-count
(one sequence) is added to each sample for each taxon. In order to
minimize the effect of this pseudo-count, all samples are
normalized to the average number of sequences per sample before
the addition of the pseudo-count.
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Statistical tests and sample size
We obtained sequences for paired exacerbation and end of
treatment timepoints for 21 patients (Table S1). For two
additional patients, we were unable to obtained sequences for
the exacerbation sample (patient 22) or the end of treatment
sample (patient 12), because sample derived total DNA was
limited. For 3 patients (patient 1, patient 11 and patient 19), we
generated sequences for second set of paired exacerbation and
end of treatment timepoints. Finally, for 13 patients (patients 1, 2,
4, 7, 8, 9, 11, 13, 14, 17, 19, 21 and 23), we collected sequences
for a stable timepoint taken either before or after the
exacerbation event.
For paired t-tests comparing exacerbation to end of treatment
timepoints (Figure 5C, Table 3), we interrogated 21 paired
samples (the second set of paired exacerbation and end of
treatment samples for patients 1, 11 and 19 were not included to
avoid violating the assumption of independence). For paired t-tests
comparing exacerbation and stable timepoints (Figure 5C,
Table 3), we considered the earliest exacerbation timepoint and
the stable timepoint to yield a samples size of 13.
Statistical tests were performed using the program JMP (http://
www.jmp.com/). PCoAs were performed in the package Mothur
(using the program pcoa) based on Bray-Curtis dissimilarity
defined as:
Pk~n
k~1
Dyik{yjkD
Pk~n
k~1
(yikzyjk)
Where yik and yjk are the log-transformed and normalized values
for taxa k in samples i and j respectively and n is the number of
taxa in all samples. Only taxa that had at least 10 total sequences
across all samples were considered in the Bray-Curtis distance
measurement.
Supporting Information
Table S1 Sample summary. Description of the 85 samples
used in this study (63 sputum, 22 mouthwash).
(TXT)
Table S2 Rank abundance of sputum OUTs. List of the
169 OTUs that were found in the CF sputum sample set, ranked
by sequence abundance.
(TXT)
Table S3 Sequence counts for each OTU by sample.
Spreadsheet of the 175 OTUs and their sequence counts for all 85
samples included in this study.
(TXT)
Table S4 RDP classification for all OTUs. RDP classifi-
cation string for 175 OTUs identified in this study.
(TXT)
Table S5 Consensus nucleotide sequence of all OTUs.
Consensus sequences for the 175 OTUs identified in this study in
FASTA format.
(TXT)
Table S6 Analyses of OTU distribution by timepoint.
Values for all taxa observed in sputum samples in this study are
given as the average log transformed normalized number of
sequences for each timepoint (Exacerbation Average, EOT
Average, Stable Average). The columns ‘‘Exacerbation Vs EOT
p Value’’ and ‘‘Exacerbation Vs Stable p Value’’ shows the results
of a null hypothesis test (evaluated with a paired t-test) that the
distribution of each taxon is the same between timepoints. The
column ‘‘Corrected P value’’ show the Benjamani-Hochberg
correction equal to N * p/rank where N is the number of rows in
the spreadsheet, p is the p-value for this row and rank is the row
number. Data was used to generate Figure 5C. Table includes
only the 163 OTUs for the sputum sample set considered in these
analyses (exacerbation, n = 21; end-of-treatment, n = 21; stable,
n = 13). The second exacerbation and end-of-treatment samples
for patients 1, 11 and 19 were not included to avoid violating the
assumption of independence.
(TXT)
Table S7 OTU abundance and prevalence. Values for the
average log10 normalized number of sequences for each taxon
(considering only the samples where the taxa was present) and the
number of samples in which the taxon is present. Data was used to
generate Figure 6.
(TXT)
Table S8 Taxa associated with Pseudomonas or Burk-
holderia culture status. The results of paired t-tests evaluating
the null hypothesis that each taxon has the same distribution in
samples identified as Pseudomonas or Burkholderia by clinical culture.
For each patient, the average for each OTU was taken across all
timepoints. The Benjamani-Hochberg method was used to
generate corrected p values. Table contains the 161 OTUs
derived from the sample set used in this analysis.
(TXT)
Table S9 Comparison of OTUs in paired sputum and
mouthwash samples. The results of parametric t-tests and
Wilcoxon tests evaluating the hypothesis that for each taxon, the
average distribution in mouthwash samples is the same as in paired
sputum samples. For all 9 patients, all samples were averaged
across all timepoints. Twenty-two paired samples from 9 patients
were treated as independent observations for the calculation of p-
values. Data was used to generate Figure 8. Table contains 161
OTUs associated with the paired samples that were analyzed.
(TXT)
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